[Functional therapeutics: official subject in gynecology. New findings in gynecology. 22nd Brazilian Meeting on Gynecology and Obstetrics].

article OA: closed CC0
View on OpenAlex View on PubMed

Abstract

During the past 5 years, after a much longer period of studies and research, new methods of treatment for several gynecological disorders have been employed. Among such new methods the most important are: 1) the use of gonadotropin-releasing hormones as contraceptive agents, to diagnose cases of hypogonadism, or to cure amenorrhea. Gonadotropin-releasing hormones can be administered in several ways, provoke different reactions in different women, and are subject to several contraindications; 2) transphenoidal surgery for hypersecretory hypophysary tumors, or microsurgery of the hypophysis, which allows the identification of tumors smaller than 10mm, and which is used in the treatment of galactorrhea; 3) the use of ergot alkaloids derivates, such as bromocriptine or Lergotrile, to provoke menstruation and ovulation; 4) the clinical use of danazol in the treatment of endometriosis and in induction of ovulation; and 5) the treatment of primary dysmenorrhea by the use of synthetic inhibitors or by the use of prostaglandins.

My notes (saved in your browser only)

Condition tags

dysmenorrheaendometriosis

MeSH descriptors

Dysmenorrhea Ergot Alkaloids Galactorrhea Pituitary Hormone-Releasing Hormones Prostaglandins Alkaloids Biology Central Nervous System Chemical Phenomena Chemistry Disease Endocrine System Hormones Menstruation Disturbances Organic Chemicals Physiology Puerperal Disorders

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-14T05:58:53.789372+00:00
License: CC0 · commercial use OK